Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1953 3
1954 1
1955 1
1956 1
1957 3
1958 5
1959 3
1960 3
1961 2
1962 2
1963 2
1964 2
1965 9
1966 3
1967 2
1968 1
1969 1
1970 2
1971 2
1972 1
1973 1
1975 1
1976 3
1977 2
1978 5
1979 2
1980 6
1981 1
1982 3
1983 4
1984 9
1985 4
1986 5
1987 3
1988 3
1989 3
1990 3
1992 1
1993 3
1994 5
1995 6
1996 3
1997 8
1998 11
1999 8
2000 9
2001 9
2002 5
2003 6
2004 9
2005 8
2006 6
2007 10
2008 16
2009 21
2010 21
2011 32
2012 34
2013 41
2014 26
2015 19
2016 16
2017 16
2018 17
2019 18
2020 22
2021 26
2022 32
2023 26
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Results by year

Filters applied: . Clear all
Page 1
Correction.
Luc M, Beaulieu MC, Breton M, Boulianne I, Champagne L, Conway S, Côté N, Deshaies JF, Fillion M, Villemure P, Hudon C. Luc M, et al. Among authors: beaulieu mc. Can Fam Physician. 2021 Apr;67(4):231. doi: 10.46747/cfp.6704231. Can Fam Physician. 2021. PMID: 33853906 Free PMC article. No abstract available.
Finding MYCure.
Beaulieu ME, Soucek L. Beaulieu ME, et al. Mol Cell Oncol. 2019 Jun 20;6(5):e1618178. doi: 10.1080/23723556.2019.1618178. eCollection 2019. Mol Cell Oncol. 2019. PMID: 31528695 Free PMC article.
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
Beaulieu ME, Jauset T, Massó-Vallés D, Martínez-Martín S, Rahl P, Maltais L, Zacarias-Fluck MF, Casacuberta-Serra S, Serrano Del Pozo E, Fiore C, Foradada L, Cano VC, Sánchez-Hervás M, Guenther M, Romero Sanz E, Oteo M, Tremblay C, Martín G, Letourneau D, Montagne M, Morcillo Alonso MÁ, Whitfield JR, Lavigne P, Soucek L. Beaulieu ME, et al. Sci Transl Med. 2019 Mar 20;11(484):eaar5012. doi: 10.1126/scitranslmed.aar5012. Sci Transl Med. 2019. PMID: 30894502 Free PMC article.
Levetiracetam.
Beaulieu MJ. Beaulieu MJ. Neonatal Netw. 2013 Jul-Aug;32(4):285-8. doi: 10.1891/0730-0832.32.4.285. Neonatal Netw. 2013. PMID: 23835548
Targeting MYC-driven lymphoma: lessons learned and future directions.
Martínez-Martín S, Beaulieu ME, Soucek L. Martínez-Martín S, et al. Among authors: beaulieu me. Cancer Drug Resist. 2023 Apr 12;6(2):205-222. doi: 10.20517/cdr.2022.127. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37457123 Free PMC article. Review.
Loading mechanisms of the anterior cruciate ligament.
Beaulieu ML, Ashton-Miller JA, Wojtys EM. Beaulieu ML, et al. Sports Biomech. 2023 Jan;22(1):1-29. doi: 10.1080/14763141.2021.1916578. Epub 2021 May 7. Sports Biomech. 2023. PMID: 33957846 Free PMC article. Review.
Effectiveness of Reablement: A Systematic Review.
Tessier A, Beaulieu MD, Mcginn CA, Latulippe R. Tessier A, et al. Among authors: beaulieu md. Healthc Policy. 2016 May;11(4):49-59. Healthc Policy. 2016. PMID: 27232236 Free PMC article. Review.
573 results